Hollenbaugh; Diane L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hollenbaugh; Diane L..The latest application filed is for "methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith".

Company Profile

0.5.6

Hollenbaugh; Diane L. - Seattle WA
Hollenbaugh; Diane L. - Mountain View CA
Hollenbaugh, Diane L. - Newton PA
Hollenbaugh, Diane L. - Newtown PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For Inhibiting An Immune Response By Blocking The Gp39/cd40 And Ctla4/cd28/b7 Pathways And Compositions For Use Therewith App 20090186037 - Larsen; Christian P. ; et al.	2009-07-23
Polynucleotides encoding humanized antibodies against human 4-1BB Grant 7,214,493 - Kunkel , et al. May 8, 2	2007-05-08
Polynucleotides encoding humanized antibodies against human 4-1BB App 20050202022 - Kunkel, Maria Jure ; et al.	2005-09-15
Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith App 20050202011 - Larsen, Christian P. ; et al.	2005-09-15
Humanized antibodies against human 4-1BB Grant 6,887,673 - Kunkel , et al. May 3, 2	2005-05-03
Humanized antibodies against human 4-1BB App 20040105855 - Kunkel, Maria Jure ; et al.	2004-06-03
Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof App 20020068346 - Krystek, Stanley R. ; et al.	2002-06-06
Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith App 20020031510 - Larsen, Christian P. ; et al.	2002-03-14
Methods for prolonging the expression of a heterologous gene of interest using soluble CTLA4 molecules and an antiCD40 ligand Grant 5,993,800 - Linsley , et al. November 30, 1	1999-11-30
Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith Grant 5,916,560 - Larsen , et al. June 29, 1	1999-06-29
Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy Grant 5,876,950 - Siadak , et al. March 2, 1	1999-03-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.